OpenVSafe by OpenVAERS
Search V-safe

A4B-12640-34985

2 vaccinations 5 coded responses 10 check-ins 5 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
221 / VA
Registered
2021-04-03
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-03
    Registered in v-safe
  2. 2021-04-03
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-03
    Survey response — day 0, dose 1
    MedDRA: Pruritus — Feeling: Fair · Headache, Fatigue or tiredness, Nausea
    Free text: Itchiness (full body)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-07
    Survey response — days 1–6 daily, dose 1
    MedDRA: Hypertension — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Very high blood pressure
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness, Nausea
    Adult check-in
  6. 2021-04-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-04-10
    Health check-in — day 7, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-04-23
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-04-24
    Dose 2 — Pfizer-BioNTech
  10. 2021-04-24
    Survey response — day 0, dose 2
    MedDRA: Dizziness — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Elevated blood pressure (significant even after medicated), nasal congestion, chest pains (intermittent), tachycardia (125- 160bpm), dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-04-24
    Report sent to call center — day 0, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  12. 2021-04-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  13. 2021-05-10
    Survey response — day 14, dose 2
    MedDRA: Chest pain — Feeling: Fair
    Free text: Intermittent sharp chest pains located in anterior upper middle section of ribcage on both sides of chest. Usually one side or the other, worse when breathing during the pain. Occasionally occurs in pulses in tandem with pulse.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-10-23
    Survey response — 6 months, dose 2
    MedDRA: Hypoaesthesia, Mobility decreased, Muscle spasms, Myalgia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Muscle spasms and pain with intermittent numbness and loss of function to lower extremities
    MedDRA releases: 2024-11 · check-in free text available
  15. 2021-10-23
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  16. 2021-10-26

Vaccinations

DoseDateManufacturerCo-administered
12021-04-03Pfizer-BioNTech
22021-04-24Pfizer-BioNTech

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 6 — day 0, dose 1

2021-04-03

Systemic reaction (other): Itchiness (full body)

Release 7 — days 1–6 daily, dose 1

2021-04-07

Systemic reaction (other): Very high blood pressure

Release 7 — day 0, dose 2

2021-04-24

Systemic reaction (other): Elevated blood pressure (significant even after medicated), nasal congestion, chest pains (intermittent), tachycardia (125- 160bpm), dizziness

Release 8 — day 14, dose 2

2021-05-10

Symptoms: Intermittent sharp chest pains located in anterior upper middle section of ribcage on both sides of chest. Usually one side or the other, worse when breathing during the pain. Occasionally occurs in pulses in tandem with pulse.

Release 10 — 6 months, dose 2

2021-10-23

Symptoms: Muscle spasms and pain with intermittent numbness and loss of function to lower extremities

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChest pain ✓ ✓ ✓
SDHypoaesthesia · · ✓
SDMobility decreased · · ✓
SDMuscle spasms · · ✓
SDMyalgia · · ✓
SRODizziness ✓ ✓ ✓
SROHypertension ✓ ✓ ✓
SROPruritus ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release